Fritextsökning
Innehållstyper
-
Multiplex Immunofluorescence
New protocol for efficient generation of seven-color, whole slide imaging with ZEISS Axioscan.
-
Insurance in Life Science: From risk to resilience
Are you visiting The Future of Swedish & Danish Life Science event in Lund 23 April? Don't miss the Gallagher seminar on Risk and Insurance in the Life Sciences sector.
-
Transport validation for medical devices
According to MDR 2017/745, “Devices shall be designed and manufactured in such a way as to ensure that their characteristics and performance during their intend...
-
ZEISS Quality Innovations Worldwide
All events now in one video.
-
Enhancing Spatial Biology
Enabling easy, reproducible multiplex spatial profiling at scale.
-
Precision, balance and clinical experience
Phase II is often the most crucial phase of clinical development. This is where the study design is validated in practice, effect must be demonstrated, and wher...
-
Breakthrough devices: Key insights from MDCG 2025-9 guidance
The Medical Device Coordination Group (MDCG) has published guidance MDCG 2025-9 to streamline the pathway for breakthrough devices (BtX) under the EU Medical De...
-
Season 2 of ZEISS Metrology Expert Tips is now live
Experts from season 1 compete against each other in #measuringhero quiz.
-
The Beauty of Clinical Microscopy of Urine Sediment
Read about concrete observations using phase contrast and polarized light.
-
From Image to Results
3D multiplexing spatial omics workflows in neuroscience.
-
Webinar: Imaging of Complex In-Vitro Models
Deep Imaging and Scalable Analysis of Hepatic Spheroids with ZEISS LSM 910/990 Lightfield 4D.
-
Optical inspection made easy
New ZEISS Smartzoom 100 product video.
-
Shaping the Future of Metrology – Live in Your Region
Insights into our event series.
-
PMS, Vigilance and Risk Management
Post-Market Surveillance (PMS) is more than complaint handling – it’s a strategic tool for patient safety, regulatory compliance, and continuous improvement. Un...
-
Could an overly burdensome QMS be the organization’s own doing?
Although the above statement is intentionally somewhat provocative, it does hold a degree of truth. Organizations that are generally negative toward regulations...
-
New version of ISO 10993-1: the core standard for the biological evaluation of medical devices
ISO 10993-1, the core standard for the biological evaluation of medical devices, has been under revision over the past few years. A Final Draft International St...
-
Integrated solutions for liquid handling
Greater efficiency for manufacturers in laboratory automation and many other industries
-
FDA’s new CSA guidance: transforming software validation for production and quality systems
FDA’s final guidance on Computer Software Assurance (CSA) for Production and Quality System Software marks a significant modernization of software validation practices.
-
Strategic Clarity: The New Currency in Life Science
In an industry shaped by rapid regulatory changes and global competition, leading life science companies are rethinking what it takes to succeed. Increasingly, ...
-
Shaping regulatory complexity into strategic clarity
As AI continues to reshape healthcare, clear guidance on health data use is more critical than ever. Building on the success of the AI Act e-tool and the Data A...
-
The FDA’s new transparency policy (Part 3)
As transparency and consistency become increasingly emphasized by the FDA, medical device manufacturers must approach their submissions with both thoroughness a...
-
The Future of Metrology is Coming to Your Region
Join our event series.
-
ZEISS EVO as the Key to Wire Technology in Modern Medicine
High-performance wires for stents.
-
IVDR Reality Check: Are We Moving Fast Enough?
As of February 2025, around 1,500 IVDR certificates have been issued. But if an estimated 18,700 devices still need certification before the 2029 deadline, then...
BREAKING